Relative Bioavailability of Different Oral Viramune Extended Release Formulations Containing 300 mg or 400 mg Compared to 200 mg or 400 mg as One or Two 200 mg IR Tablets Following Administration in Healthy Male Volunteers - an Openlabel, Non-randomized, Parallel Group Study
Latest Information Update: 21 Jul 2014
Price :
$35 *
At a glance
- Drugs Nevirapine (Primary) ; Nevirapine
- Indications HIV infections; HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 21 Jul 2014 New trial record